Published in Drug Alcohol Depend on November 11, 2008
Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis (2010) 2.32
Fire in the vein: Heroin acidity and its proximal effect on users' health. Int J Drug Policy (2015) 2.13
Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.84
Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume. PLoS One (2015) 1.41
Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.31
Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania. Eur Addict Res (2010) 1.02
Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health (2014) 0.96
A needle in the haystack - the dire straits of needle exchange in Hungary. BMC Public Health (2016) 0.88
Social marketing of low dead space syringes in Vietnam: findings from a 1-year pilot program in Hanoi, Thai Nguyen, and Ho Chi Minh City. Harm Reduct J (2015) 0.77
High dead-space syringe use among people who inject drugs in Tijuana, Mexico. Am J Drug Alcohol Abuse (2015) 0.77
Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs. Am J Public Health (2015) 0.75
Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes. AIDS Res Hum Retroviruses (2016) 0.75
The HIV-1 transmission bottleneck. Retrovirology (2017) 0.75
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30
The social structural production of HIV risk among injecting drug users. Soc Sci Med (2005) 7.78
Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol (2000) 7.77
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med (1997) 7.11
Matching using estimated propensity scores: relating theory to practice. Biometrics (1996) 6.73
Global overview of injecting drug use and HIV infection among injecting drug users. AIDS (2004) 5.45
Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health (2001) 4.57
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20
Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis (2002) 3.83
Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72
Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32
Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A (2007) 3.29
Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol (2000) 2.95
Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS (2002) 2.74
Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis (1994) 2.55
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest (2008) 2.12
Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 2.10
HIV and HCV infection among injecting drug users. Mt Sinai J Med (2000) 1.96
Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med (1996) 1.93
Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction (2006) 1.87
Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav (2005) 1.84
Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse (2003) 1.74
HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1. J Acquir Immune Defic Syndr (1999) 1.72
Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS (2006) 1.70
A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr (1992) 1.65
HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med (2008) 1.59
Evaluation of needle and syringe combinations. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.43
HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health (2005) 1.31
Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.27
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health (2004) 1.26
Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond. Public Health Rep (1998) 1.24
Syringe type and drug injector risk for HIV infection: a case study in Texas. Soc Sci Med (2002) 1.14
Risk and reciprocity: HIV and the injection drug user. J Psychoactive Drugs (1992) 1.12
Survival of HIV-1 in syringes: effects of temperature during storage. Subst Use Misuse (2000) 1.06
Reaching and enrolling drug users for HIV prevention: a multi-site analysis. Drug Alcohol Depend (1999) 1.05
Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey. Harm Reduct J (2006) 1.04
Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc (Wash) (2002) 1.04
Update on male circumcision: prevention success and challenges ahead. Curr Infect Dis Rep (2008) 0.97
Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users. Am J Public Health (2009) 0.96
Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS (1991) 0.96
Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001. J Urban Health (2002) 0.94
Male circumcision and prevention of HIV and sexually transmitted infections. Curr Infect Dis Rep (2008) 0.92
Pandemic influenza preparedness: the critical role of the syringe. Vaccine (2006) 0.86
Injection drug users and pharmacists: a call for compassion, cooperation, and care. J Am Pharm Assoc (Wash) (2002) 0.84
Jabs in the dark: injecting equipment found in prisons, and the risks of viral transmission. Aust J Public Health (1994) 0.76
Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health (2004) 2.50
Prediction of death for extremely low birth weight neonates. Pediatrics (2005) 1.50
Quantifying interhospital patient sharing as a mechanism for infectious disease spread. Infect Control Hosp Epidemiol (2010) 1.39
Researching a local heroin market as a complex adaptive system. Am J Community Psychol (2009) 1.23
Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants. Pediatrics (2010) 1.21
Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend (2007) 1.08
Re: "Detecting patterns of occupational illness clustering with alternating logistic regressions applied to longitudinal data". Am J Epidemiol (2004) 1.01
When budgets are tight, there are better options than colonoscopies for colorectal cancer screening. Health Aff (Millwood) (2010) 0.98
Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial. Subst Abuse Treat Prev Policy (2012) 0.97
Drug use opportunities as opportunities for drug use prevention: Bogotá, Colombia a case in point. Drug Alcohol Depend (2011) 0.92
Description of the methodology used in an ongoing pediatric care interventional study of children born with cleft lip and palate in South America [NCT00097149]. BMC Pediatr (2006) 0.91
Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiol Biomarkers Prev (2009) 0.91
Understanding the relative influence of neighborhood, family, and youth on adolescent drug use. Subst Use Misuse (2007) 0.91
The simulation of addiction: pharmacological and neurocomputational models of drug self-administration. Drug Alcohol Depend (2007) 0.78
Random forest methodology for model-based recursive partitioning: the mobForest package for R. BMC Bioinformatics (2013) 0.77
Sweet-liking is associated with transformation of heavy drinking into alcohol-related problems in young adults with high novelty seeking. Alcohol Clin Exp Res (2014) 0.77
Comprehensive mathematical modeling in drug addiction sciences. Drug Alcohol Depend (2007) 0.76
Synthesizing Marketing, Community Engagement, and Systems Science Approaches for Advancing Translational Research. ANS Adv Nurs Sci (2015) 0.75